Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Profile of hMSH2 expression in breast tumors and lymph nodes: a preliminary study

Full text
Author(s):
Lira, D. [1] ; Teodoro, T. R. [1] ; Da Silva Pinhal, M. A. [1] ; Affonso Fonseca, F. L. [2, 1] ; De Sousa Gehrke, F. [1] ; Azzalis, L. A. [2] ; De Campos Junqueira, V. B. [2] ; Da Costa Aguiar Alves, B. [1]
Total Authors: 8
Affiliation:
[1] ABC Med Sch, Dept Oncol, Santo Andre, SP - Brazil
[2] UNIFESP, Dept Biol Sci, Diadema, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES; v. 19, n. 17, p. 3229-3233, SEP 2015.
Web of Science Citations: 2
Abstract

OBJECTIVE: The mismatch repair (MMR) genes play a central role for the onset of cancer. One of these genes is hMSH2. A differential hMSH2 protein expression has been detected in the mononuclear fraction of peripheral blood of patients with breast cancer when compared to healthy women. This work aims to evaluate the expression of hMSH2 in patients diagnosed with breast cancer undergoing treatment at various stages of the disease to verify its potential use as a prognostic marker. PATIENTS AND METHODS: Immunohistochemical expression of hMSH2 at different stages of breast cancer in 40 patients biopsy samples were analyzed. RESULTS: hMSH2 has a considerable increased expression in all groups of patients with tumors, when compared to patients without tumors. CONCLUSIONS: immunohistochemistry indeed can be a great tool for the diagnosis of breast cancer, as it is an easy and versatile technique. (AU)

FAPESP's process: 14/17693-1 - Evaluation of prognostic value of monocarboxilate transporters (MCT) in patients with breast cancer
Grantee:Beatriz da Costa Aguiar Alves Reis
Support Opportunities: Regular Research Grants